Target Name: RNF113A
NCBI ID: G7737
Review Report on RNF113A Target / Biomarker Content of Review Report on RNF113A Target / Biomarker
RNF113A
Other Name(s): Cwc24 homolog | Ring finger protein 113A | Zinc finger protein 183 | Zinc finger protein 183 (RING finger, C3HC4 type) | ring finger protein 113A | RING finger protein 113A | zinc finger protein 183 (RING finger, C3HC4 type) | ZNF183 | E3 ubiquitin-protein ligase RNF113A | Cwc24 | cwc24 homolog | R113A_HUMAN | RNF113 | TTD5

The Cwc24 Homolog: A Potential Drug Target and Biomarker

RNA-Nucleic Acid (RNA) fingerprints are a type of genetic fingerprint that are derived from the unique DNA sequence of an organism. They are used to identify and quantify the diversity of DNA within an organism, as well as to identify potential drug targets, biomarkers, and disease-causing variants. One of the most well-known RNA-Nucleic Acid fingerprints is the Cwc24 homolog, which is a region of DNA that is highly conserved across many different organisms. The Cwc24 homolog is a potential drug target and biomarker in many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The Cwc24 homolog is located on chromosome 16 and consists of approximately 1,200 base pairs of DNA. It is characterized by a high degree of conservation, with only a few minor differences in the nucleotide sequences at different positions. The Cwc24 homolog is conserved across many different organisms, including humans, and has been identified in many different species, including bacteria, yeast, and plants.

The Cwc24 homolog is involved in many different cellular processes in the cell, including DNA replication, transcription, and gene regulation. It is a key region of the genome that is involved in the regulation of gene expression and has been implicated in the development and progression of many different diseases.

One of the most promising aspects of the Cwc24 homolog is its potential as a drug target. The Cwc24 homolog has been shown to be involved in the regulation of many different cellular processes, including cell growth, apoptosis, and inflammation. Many different drugs, including anti-cancer drugs, have been shown to target the Cwc24 homolog in order to inhibit its activity and prevent the development of cancer.

In addition to its potential as a drug target, the Cwc24 homolog is also a potential biomarker for many different diseases. Its high degree of conservation across many different organisms makes it a good candidate for use as a diagnostic marker for many different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The Cwc24 homolog is also of interest to researchers who are studying the role of DNA replication in the development and progression of cancer. Many researchers believe that the Cwc24 homolog is involved in the regulation of DNA replication and that its activity may be important for the development of cancer.

In conclusion, the Cwc24 homolog is a region of DNA that is highly conserved across many different organisms and is involved in many different cellular processes in the cell. Its high degree of conservation and its involvement in the regulation of many different cellular processes make it a promising candidate as a drug target and biomarker for many different diseases. Further research is needed to fully understand the role of the Cwc24 homolog in the development and progression of many different diseases.

Protein Name: Ring Finger Protein 113A

Functions: Required for pre-mRNA splicing as component of the spliceosome (PubMed:29361316, PubMed:29360106). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). E3 ubiquitin-protein ligase that catalyzes the transfer of ubiquitin onto target proteins (PubMed:28978524, PubMed:29144457). Catalyzes polyubiquitination of SNRNP200/BRR2 with non-canonical 'Lys-63'-linked polyubiquitin chains (PubMed:29144457). Plays a role in DNA repair via its role in the synthesis of 'Lys-63'-linked polyubiquitin chains that recruit ALKBH3 and the ASCC complex to sites of DNA damage by alkylating agents (PubMed:29144457). Ubiquitinates CXCR4, leading to its degradation, and thereby contributes to the termination of CXCR4 signaling (PubMed:28978524)

The "RNF113A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNF113A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6 | RNF7 | RNF7P1 | RNF8 | RNFT1 | RNFT2 | RNGTT | RNH1 | RNLS | RNMT | RNPC3 | RNPC3-DT | RNPEP | RNPEPL1 | RNPS1 | RNPS1P1